Download PDFPDF
O-010 The Barrow Neurological Institute Experience with the Pipeline Embolisation Device: Results in the First 100 Patients Treated after FDA Approval
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address